 - Women with stages II-IV epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who have completed standard therapy for primary or recurrent disease i.e., patients who would normally be observed; eligible patients may have asymptomatic residual measurable disease on physical examination andor computed tomography CT scan, andor may have an elevated cancer antigen 125 CA-125; or may be in complete clinical remission after treatment for primary or recurrent disease; these patients would normally enter a period of observation after standard management 